Some Biologic Treatments for Psoriasis May Be Safer for Patients
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
The Women and Equalities Committee's report highlights patient safety failures tied to unregulated surgical and non-surgical cosmetic procedures, including gaps in data collection, informed consent, and clinical oversight.